Perspective · 29 Dec 2025
OpinionPublished 30 Jun 2025
CRISPR-Cas Gene Editing in Cancer: A Transformative Frontier in Clinical Oncology
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
CRISPR-Cas gene editing has emerged as one of the most revolutionary technologies in modern biomedical science, offering unprecedented precision in manipulating the human genome. In oncology, CRISPR has reshaped approaches to cancer modeling, diagnosis, and therapy by enabling targeted modification of oncogenes, tumor suppressor genes, and immune pathways. This opinion article explores the evolving role of CRISPR in clinical oncology, highlighting its therapeutic promise, translational barriers, ethical considerations, and future prospects. While early clinical trials show encouraging safety and efficacy signals, significant challenges—including off-target effects, delivery limitations, tumor heterogeneity, and regulatory constraints—continue to restrict widespread clinical adoption. The article argues that CRISPR is not a standalone cure but a foundational enabling platform that, when integrated with immunotherapy and precision medicine, could redefine cancer treatment paradigms.
Keywords
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Reports in Cancer and Treatment.
Commentary · 29 Dec 2025
Rethinking Colorectal Cancer: From Silent Progression to Preventive Precision
Opinion · 29 Dec 2025
Rewiring the Immune Battlefield: The Transformative Promise of Immunotherapy in Lung Cancer
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalReports in Cancer and Treatment
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Michael R. Ellington”